PON2 and lung adenocarcinoma: Given that loss of PON2 expression was detrimental to lung adenocarcinoma cell proliferation (Fig. 2), we sought to investigate the impact of PON2 on cellular bioenergetics through a stable isotope resolved metabolomics (SIRM) approach.